immu-132 - a novel antibody-drug conjugate for the treatment of lung cancer
Published 7 years ago • 547 plays • Length 2:06Download video MP4
Download video MP3
Similar videos
-
3:58
antibody drug conjugates in lung cancer
-
1:09
dr. guarino on immu-132 in advanced metastatic lung cancer
-
2:26
exploring antibody-drug conjugates (adcs) in lung cancer
-
3:24
novel immunotherapy agents on the horizon for lung cancer
-
28:19
s3 episode 4: the future of antibody-drug conjugates in lung cancer treatment
-
27:03
antibody drug conjugates: the end of chemotherapy | 2023 west oncology conference
-
1:33
antibody-drug conjugates (adcs) in nsclc
-
3:05
antibody drug conjugate treatment in lung cancer - onctalk lung 2023
-
1:49
adcs for lung cancer
-
1:58
the role of antibody drug conjugates in lung cancer care
-
2:30
the future of antibody-drug conjugates in urothelial cancer
-
2:07
emerging toxicities associated with adcs
-
56:32
antibody drug conjugates for cancer
-
1:56
using emibetuzumab directed towards met for the treatment of lung cancer
-
1:24
adcs in lung cancer treatment
-
6:22
what are antibody drug conjugates?
-
7:29
antibody drug conjugates: what are antibodies? - onctalk lung 2023
-
3:45
imgn632: a novel cd123 adc for r/r aml and bpdcn
-
2:03
recent antibody-drug conjugate approvals in gynecologic malignancies